Overview

Endo International plc is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA.
DateTitle 
08/22/17Endo to Participate at Morgan Stanley Global Healthcare ConferencePrinter Friendly Version
08/08/17Endo Reports Second-Quarter 2017 Financial ResultsPrinter Friendly Version
08/07/17Endo Announces Agreements to Resolve Virtually All Known U.S. Mesh Product Liability ClaimsPrinter Friendly Version
07/21/17Endo to Restructure Manufacturing NetworkPrinter Friendly Version
What's New
DateTitle
08/17/17
Download Documentation Corporate Fact Sheet
04/28/17
Download Documentation 2016 Annual Report
01/09/17
Download Documentation J.P. Morgan Healthcare Conference Presentation – January 9, 2017
Get help downloading or viewing the above file types


Print Page Print Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts

Investor Relations / Media Contact:
Stephen Mock
Senior Vice President, Investor Relations and Corporate Affairs
845-364-4833
Email: mock.stephen@endo.com

Investors Relations Contact:
Nina Goworek
Senior Director, Investor Relations
484-216-6657
Email: goworek.nina@endo.com  

Media Contact:
Heather Zoumas-Lubeski
Senior Director,
Corporate Affairs
484-216-6829
Email: zoumaslubeski.heather@endo.com

Receive E-mail AlertsE-mail Alert Icon
You may automatically receive Endo Pharmaceuticals news and financial information by email. To choose your options for email notification, please enter your email address below and click Submit. To change your email options at any time, re-enter your email address and click Submit, then adjust your form entries.